The company was established in 1995. After years of development, it now has several production bases and hundreds of products covering many therapeutic fields. During the epidemic period, Hongri Pharmaceutical actively responded to the call of the state, deployed production lines, and increased the production of vaccines, masks and other epidemic prevention materials, making contributions to the fight against the epidemic. At present, Hongri Pharmaceutical continues to promote enterprise transformation and upgrading, strengthen innovation capability and brand building, actively expand overseas markets and maintain steady development. Although the company's performance fluctuates due to factors such as epidemic situation and industrial policy adjustment, investors are optimistic about its future development prospects as a whole.